Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a poop pill save lives? new trial tests fecal transplants for ICU patients with superbug lung infections

NCT ID NCT06970262

First seen Jan 07, 2026 · Last updated May 23, 2026 · Updated 18 times

Summary

This study tests whether fecal microbiota transplantation (FMT) — transferring healthy donor stool into the gut — can reduce deaths in ventilated ICU patients with multidrug-resistant lung infections. The idea is that restoring gut bacteria may help fight lung infections through the gut-lung connection. About 60 adults will receive either standard care or standard care plus FMT via a feeding tube, and researchers will track survival at 28 days.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MICROBIAL COLONIZATION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Department of Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    Wuhan, China

    Contact

Conditions

Explore the condition pages connected to this study.